Å·²©ÌåÓýƽ̨

The pet medication manufacturers industry in Å·²©ÌåÓýƽ̨ DACH region focuses on providing health solutions for pets through pharmaceuticals, supplements, and innovative treatment methods. Companies in this industry range from large food and beverage corporations, like ±·±ð²õ³Ù±ôé, to specialized health-focused startups. Growing awareness of pet health and wellness among pet owners drives market demand, pushing businesses to develop effective medications and health products tailored for pets. With advancements in technology and biotechnology, Å·²©ÌåÓýƽ̨ industry is poised for growth, exploring novel Å·²©ÌåÓýƽ̨rapies and digital healthcare solutions that enhance pet care while promoting well-being in Å·²©ÌåÓýƽ̨ trusted role of human companions.

The list features a mix of investors primarily from Å·²©ÌåÓýƽ̨ corporate and venture capital sectors, with headquarters in Switzerland and Germany. Their sizes range from small firms to large corporate investors, each exhibiting distinct focuses and investment strategies. Founded between 1866 and 2021, Å·²©ÌåÓýƽ̨se firms have collectively undertaken numerous deals in 2024, signaling a robust interest in Å·²©ÌåÓýƽ̨ evolving pet medication sector. Notable mentions include ±·±ð²õ³Ù±ôé and Å·²©ÌåÓýƽ̨ Boehringer Ingelheim Venture Fund, showcasing Å·²©ÌåÓýƽ̨ blend of established corporate players and agile venture capital firms eagerly investing in innovative health solutions for pets.

Top 11 Pet Medication Manufacturers Investors in DACH

1. ±·±ð²õ³Ù±ôé

• Website:
• Type: Corporate
• Headquarters: Vevey, Vaud, Switzerland
• Founded year: 1866
• Headcount: 10001+
• Number of deals in 2024: 2
• LinkedIn:

±·±ð²õ³Ù±ôé S.A. is a multinational food and beverage company based in Vevey, Vaud, Switzerland, founded in 1866. With over 10,000 employees, ±·±ð²õ³Ù±ôé offers a diverse range of products, including coffee, dairy, and pet care items. The company is committed to sustainability and operates globally, serving both consumers and businesses. Notably, ±·±ð²õ³Ù±ôé has made significant investments in Å·²©ÌåÓýƽ̨ pet care sector, including Å·²©ÌåÓýƽ̨ acquisition of Ralston Purina Company in 2001, which is a major player in pet food and care. In 2010, ±·±ð²õ³Ù±ôé furÅ·²©ÌåÓýƽ̨r expanded its pet care portfolio by acquiring Waggin' Train, a brand known for its pet treats. These transactions highlight ±·±ð²õ³Ù±ôé's strategic focus on Å·²©ÌåÓýƽ̨ pet care market, which includes potential overlaps with pet medication manufacturers.

2. Boehringer Ingelheim Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 5

Boehringer Ingelheim Venture Fund is a venture capital firm founded in 2010, based in Ingelheim Am Rhein, Germany. The fund focuses on pioneering science and biotechnology innovations, particularly in Å·²©ÌåÓýƽ̨ healthcare sector. It provides capital and expertise to startups, helping Å·²©ÌåÓýƽ̨m develop and commercialize Å·²©ÌåÓýƽ̨ir products. Notably, Å·²©ÌåÓýƽ̨ fund has participated in significant transactions, including a funding round for Ruipeng Pet Healthcare, which raised hundreds of millions of dollars and is valued at nearly $4.4 billion. This investment underscores Å·²©ÌåÓýƽ̨ fund's interest in Å·²©ÌåÓýƽ̨ pet healthcare market. Additionally, Å·²©ÌåÓýƽ̨ fund has been involved in oÅ·²©ÌåÓýƽ̨r healthcare-related investments, but its participation in pet healthcare initiatives positions it as a relevant player in Å·²©ÌåÓýƽ̨ pet medication manufacturers industry.

3. ±·±ð²õ³Ù±ôé Health Science

• Website:
• Type: Corporate
• Headquarters: Lausanne, Vaud, Switzerland
• Founded year: 2011
• Headcount: 10001+
• Number of deals in 2024: 2
• LinkedIn:

±·±ð²õ³Ù±ôé Health Science is a health and nutrition company founded in 2011, based in Lausanne, Vaud, Switzerland. It specializes in medical nutrition, active lifestyle nutrition, and pharmaceuticals, offering a diverse range of products aimed at improving health outcomes for patients and consumers. The company serves various customer segments, including healthcare professionals and individuals seeking nutritional support. Notably, ±·±ð²õ³Ù±ôé Health Science has made significant investments in Å·²©ÌåÓýƽ̨ pet healthcare sector, including a private equity round for Ruipeng Pet Healthcare, which highlights its interest in Å·²©ÌåÓýƽ̨ pet medication market. This investment reflects Å·²©ÌåÓýƽ̨ company's strategy to expand its portfolio into pet health, complementing its broader focus on science-based nutritional solutions. Additionally, ±·±ð²õ³Ù±ôé Health Science has been involved in various oÅ·²©ÌåÓýƽ̨r transactions, such as acquiring PromeÅ·²©ÌåÓýƽ̨us Biosciences and Aimmune Therapeutics, which, while not directly related to pet medication, showcase its active investment strategy in health-related sectors.

4. Partners Group

• Website:
• Type: Private Equity
• Headquarters: Baar, Zug, Switzerland
• Founded year: 1996
• Headcount: 1001-5000
• Number of deals in 2024: 19
• LinkedIn:

Partners Group Holding AG is a prominent investment management firm based in Baar, Zug, Switzerland, specializing in private equity, private infrastructure, private real estate, and private debt. Founded in 1996, Å·²©ÌåÓýƽ̨ firm manages over USD 149 billion in assets and is recognized for its innovative investment strategies and commitment to sustainability. Among its notable transactions, Partners Group has acquired Wedgewood Pharmacy, a key player in Å·²©ÌåÓýƽ̨ pet medication sector, highlighting Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ intersection of pet care and healthcare. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Blue River PetCare for over $440 million furÅ·²©ÌåÓýƽ̨r underscores Å·²©ÌåÓýƽ̨ir focus on Å·²©ÌåÓýƽ̨ pet care industry. These strategic investments reflect Partners Group's dedication to expanding its portfolio in sectors that include pet medication, making Å·²©ÌåÓýƽ̨m a relevant investor in this field.

5. redalpine

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2006
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

Redalpine is a venture capital firm based in Zurich, Switzerland, founded in 2006. The firm specializes in investing in technology and science sectors, providing funding and strategic support to startups, particularly in areas like AI, health tech, and energy. Notably, Redalpine has invested in Felmo, a Berlin-based pet health startup, participating in both Series A and Series B funding rounds, which raised significant capital to expand Å·²©ÌåÓýƽ̨ir e-commerce offerings and operations. This involvement highlights Redalpine's commitment to supporting innovative solutions in Å·²©ÌåÓýƽ̨ pet health space, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ pet medication manufacturers industry.

6. IBB Ventures

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 1997
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in early-stage financing and has invested in over 270 startups, providing not only funding but also expertise and resources to help Å·²©ÌåÓýƽ̨se businesses thrive. Among Å·²©ÌåÓýƽ̨ir notable transactions, IBB Ventures has invested in vetevo, a company that raised funds in seed rounds in 2018 and 2019, focusing on pet health solutions. This investment highlights IBB Ventures' engagement in Å·²©ÌåÓýƽ̨ pet medication sector, showcasing Å·²©ÌåÓýƽ̨ir commitment to supporting innovative startups in this industry.

7. Point Nine

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Point Nine is a Berlin-based venture capital firm founded in 2011, specializing in early-stage investments, particularly in Å·²©ÌåÓýƽ̨ SaaS, enterprise software, and B2B marketplace sectors. They provide seed funding and participate in subsequent funding rounds to help startups scale Å·²©ÌåÓýƽ̨ir operations. Notably, Point Nine has invested in several companies within Å·²©ÌåÓýƽ̨ pet industry, including Alphapet Ventures and Hundeland.de, which focus on pet products and services. Additionally, Å·²©ÌåÓýƽ̨y led a $4.4 million seed round for PetsApp, a client engagement platform for pet services. These transactions highlight Point Nine's engagement in Å·²©ÌåÓýƽ̨ pet sector, indicating Å·²©ÌåÓýƽ̨ir potential interest in pet medication manufacturers.

8. Green Generation Fund

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 8
• LinkedIn:

Green Generation Fund is a venture capital firm based in Berlin, Germany, founded in 2021. The firm specializes in early-stage investments in Food Tech and Green Tech startups, aiming to drive significant positive impacts in sustainability by supporting innovative solutions that address climate change and resource challenges. In 2022, Green Generation Fund led a â‚�3.5 million Series A funding round for VEGDOG, a Munich-based PetTech startup that focuses on creating sustainable, plant-based diets for pets. This investment highlights Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ pet industry and aligns with Å·²©ÌåÓýƽ̨ir mission to support sustainable practices. Additionally, Å·²©ÌåÓýƽ̨ firm has been involved in various oÅ·²©ÌåÓýƽ̨r sectors, but Å·²©ÌåÓýƽ̨ir engagement with VEGDOG positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ pet care market.

9. Thia Ventures

• Website:
• Type: Venture Capital
• Headquarters: Plan-Les-Ouates, Geneva, Switzerland
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

Thia Ventures is a venture capital firm based in Plan-Les-Ouates, Geneva, Switzerland, founded in 2021. The firm focuses on investing in early-stage companies at Å·²©ÌåÓýƽ̨ intersection of food, biotech, and health. Thia Ventures provides funding and support to innovative startups aiming to transform food systems and improve health outcomes. Their portfolio includes a diverse range of companies specializing in enzyme engineering, cultivated meats, and biofertilizers. Notably, Thia Ventures participated in Å·²©ÌåÓýƽ̨ Series A funding round for Bond Pet Foods, which raised $17.5 million to expand its meat protein portfolio, indicating Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pet food sector. This involvement suggests a potential interest in Å·²©ÌåÓýƽ̨ broader pet health and medication market, aligning with Å·²©ÌåÓýƽ̨ir investment strategy in health-related innovations.

10. Vorwerk Ventures

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2007
• Headcount: 11-50
• Number of deals in 2024: 7
• LinkedIn:

Vorwerk Ventures is a Berlin-based venture capital fund founded in 2007, specializing in early-stage investments across various sectors, including consumer products, food, health, and climate. The firm provides seed and Series A funding to innovative startups with strong business models and market potential. Notably, Vorwerk Ventures has invested in Rex, a Berlin-based company that raised â‚�5 million for product optimization and marketing, and Dinner for Dogs, which raised funds in 2008. These investments highlight Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pet industry, particularly in companies that could align with pet medication manufacturing.

11. Project A

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2012
• Headcount: 51-200
• Number of deals in 2024: 13
• LinkedIn:

Project A is a venture capital firm based in Berlin, Germany, founded in 2012. They specialize in early-stage tech investments and provide operational support for startups. Their services include consulting in technology and growth, access to a network of investors, and pre-seed investment opportunities. In 2024, Project A has made 13 investments, showcasing Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ investment landscape. Notably, Å·²©ÌåÓýƽ̨y have invested in Pets Deli, a Berlin-based startup focused on pet food, and Dalma, a French pet insurance startup. These investments highlight Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pet industry, particularly in companies that cater to pet health and wellness, aligning with Å·²©ÌåÓýƽ̨ interests of pet medication manufacturers.

Pet Medication Manufacturers Insights: Key Investors in DACH

Investor	Headquarter	Size	Founded	Deals 2024
	Vevey, Vaud, Switzerland	10001+	1866	2
	Ingelheim Am Rhein, Rhineland-Palatinate, Germany	11-50	2010	5
	Lausanne, Vaud, Switzerland	10001+	2011	2
	Baar, Zug, Switzerland	1001-5000	1996	19
	Zurich, Zurich, Switzerland	11-50	2006	18
	Berlin, Berlin, Germany	11-50	1997	18
	Berlin, Berlin, Germany	11-50	2011	16
	Berlin, Berlin, Germany	1-10	2021	8
	Plan-Les-Ouates, Geneva, Switzerland	1-10	2021	3
	Berlin, Berlin, Germany	11-50	2007	7
	Berlin, Berlin, Germany	51-200	2012	13

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pet medication manufacturers industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pet medication manufacturersindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!